Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Ramdicivir and Baricitinib Combination Therapy for the Treatment of COVID 19 ARDS

NCT04693026 is registered in ClinicalTrials.gov with M Abdur Rahim Medical College and Hospital as lead sponsor.

NCT NCT04693026
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04693026 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Ramdicivir and Baricitinib Combination Therapy for the Treatment of COVID 19 ARDS
Lead sponsor
M Abdur Rahim Medical College and Hospital
Phase
Phase 3
Overall status
Unknown status
Start date
September 10, 2020
Completion date
March 5, 2021
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19 ards, covid19